Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Market Videos
Currencies
International
Treasury & Bonds
Search InvestCenter
Recent Quotes
My Watchlist
Indicators
(NQ: )
N/A   UNCHANGED
Last Price  /  Updated:   /  Add to My Watchlist      
View: Quote News
Press releases about
 
< Previous 1 2 3 Next >
AtheroGenics Provides Update on Bankruptcy Proceedings
January 22, 2009
No Proceeds From Liquidation Expected to Be Available for Shareholders Read More
from Marketwired News Releases
AtheroGenics Reports Third Quarter 2008 Financial Results
November 10, 2008
from Marketwired News Releases
AtheroGenics Receives Delisting Notice From NASDAQ Global Market Due to Chapter 11 Filing
October 10, 2008
from Marketwired News Releases
Zacks Analyst Blog Highlights: Wipro, Ltd., Skechers USA, Inc., Coca-Cola Hellenic Bottling Co., Scientific Games Corp. and AtheroGenics, Inc.
October 08, 2008
from Business Wire News Releases
AtheroGenics Files for Chapter 11 Bankruptcy
October 07, 2008
from Marketwired News Releases
Zacks Analyst Blog Highlights: Toyota Motor Corp., Jamba, Inc., AtheroGenics, Inc., Vodafone Group Plc. and Xilinx, Inc.
October 01, 2008
from Business Wire News Releases
AtheroGenics Restructures Board of Directors
September 10, 2008
from Marketwired News Releases
BellwetherReport.com Analyst Opinions on SCRX, AGIX, BUCY and ISIL
September 02, 2008
NOTE TO EDITORS: The Following Is an Investment Opinion Being Issued by The Bellwether Report. Read More
from Marketwired News Releases
AtheroGenics Seeks to Realign Capital Structure
September 02, 2008
Will Not Repay 2008 Notes at Maturity Read More
from Marketwired News Releases
AtheroGenics Reports Second Quarter 2008 Financial Results
August 05, 2008
from Marketwired News Releases
BeaconEquity.com Issues Technical Trade Alerts on Market Movers: AGIX, APKT, BIOS, NOVA, CNXT, CHRD
August 01, 2008
from PR Newswire
BellwetherReport.com Analyst Report on HOLX, AKAM, SBUX and AGIX
July 31, 2008
NOTE TO EDITORS: The Following Is an Investment Opinion Being Issued by The Bellwether Report. Read More
from Marketwired News Releases
AtheroGenics Reports Positive Results From ANDES Phase 3 Clinical Trial of AGI-1067 in Type 2 Diabetes
July 31, 2008
Company to Host Conference Call and Webcast on July 31, 2008 at 9 a.m. EDT Read More
from Marketwired News Releases
AtheroGenics to Report Second Quarter 2008 Financial Results on August 5, 2008
July 25, 2008
from Marketwired News Releases
AtheroGenics Receives Notice of Non-Compliance With Listing Requirement for the NASDAQ Global Market
June 30, 2008
from Marketwired News Releases
BeaconEquity.com Issues TraderNotes on Stocks: TPIM, NSM, BRLC, AGIX, AROX, TLEO, HLYS, ABAT
June 19, 2008
from PR Newswire
AtheroGenics Reports Clinical Data on Novel Anti-Inflammatory Anti-Oxidant Agent, AGI-1067, at American Diabetes Association Annual Meeting
June 10, 2008
from Marketwired News Releases
AtheroGenics Announces Five Abstracts Accepted for the American Diabetes Association's 68th Annual Scientific Sessions
June 04, 2008
from Marketwired News Releases
AtheroGenics' ARISE Trial Results Published in The Lancet
May 22, 2008
from Marketwired News Releases
Semi-Annual Changes to the NASDAQ Biotechnology Index
May 09, 2008
from GlobeNewswire News Releases
Semi-Annual Changes to the NASDAQ Biotechnology Index
May 09, 2008
from GlobeNewswire News Releases
/ CORRECTION - AtheroGenics to Present at the 2008 Morgan Stanley Global Healthcare Unplugged Conference on May 2, 2008
April 30, 2008
from Marketwired News Releases
AtheroGenics to Present at the 2008 Morgan Stanley Global Healthcare Unplugged Conference on May 2, 2008
April 30, 2008
from Marketwired News Releases
AtheroGenics Reports First Quarter 2008 Financial Results
April 24, 2008
from Marketwired News Releases
AtheroGenics to Report First Quarter 2008 Financial Results on April 24, 2008
April 17, 2008
from Marketwired News Releases
BellwetherReport.com Initiates Analyst Coverage on AGIX, FRNT, AAI and BBI
April 14, 2008
NOTE TO EDITORS: The Following Is an Investment Opinion Being Issued by The Bellwether Report. Read More
from Marketwired News Releases
AtheroGenics Announces Encouraging Interim Results From Phase 3 Clinical Trial of AGI-1067 in Type 2 Diabetes
April 14, 2008
Company to Host Conference Call and Webcast on April 14, 2008 at 9 a.m. EDT Read More
from Marketwired News Releases
AtheroGenics to Present at Lehman Brothers Global Healthcare Conference March 18, 2008
March 11, 2008
from Marketwired News Releases
AtheroGenics Regains Compliance With NASDAQ Listing Requirement
March 04, 2008
from Marketwired News Releases
AtheroGenics Reports Fourth Quarter and Year-End 2007 Financial Results
February 14, 2008
from Marketwired News Releases
< Previous 1 2 3 Next >
Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Telekurs USA
Postage Rates Bots go here